Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.
The most Disruptive AI based toolset For drug discovery on the market Our platform uses AI to help you speed up your drug discovery processes. Together we can make a big difference Recognizing the sig
All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.
How it describes itself
Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.
Seen November 2026 · 1 capture · latest observed messagingDesign without structure. Screen against everything.
Ainnocence designs binders from sequence alone — no crystal structure, no docking, no predicted-fold error to inherit. The same sequence-first design screens antibodies against the surface and circula
July 2025 – March 2026 · 4 capturesCure the incurables
Cure the incurables Ainnocence is a global biotech company that leads in generative AI for therapeutic discovery, leveraging industry grade sequence-based proprietary technology and training data from
Seen January 2025 · 1 captureSimplicity Constitutes Supreme Excellence
Simplicity Constitutes Supreme Excellence Ainnocence is a global AI Biotech company leading virtual screening, scientific intelligence, and molecular generative AI. Log In Schedule a Meeting Transform
Seen July 2024 · 1 captureAntibody de novo design, Humanization, Affinity maturation
Experience the future of AI drug discovery, from antibody and protein design to epitopemapping and binding optimization. Explore groundbreaking solutions at AInnocence.
October 2023 – March 2024 · 2 capturesAI Drug Discovery| AI off Targeting Screening Design
Experience the future of AI drug discovery, from antibody and protein design to epitopemapping and binding optimization. Explore groundbreaking solutions at AInnocence.